Tango Therapeutics Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Tango Therapeutics Inc 公司

Tango Therapeutics, Inc. 是一家臨牀階段的生物技術公司，致力於發現新型藥物靶點並提供用於治療癌症的精準醫療。該公司利用合成致死的遺傳原理來發現和開發針對癌症關鍵靶點的療法。這包括將精準腫瘤學靶點的範圍擴展到新領域，例如腫瘤抑制基因缺失及其對癌細胞逃避免疫細胞殺傷能力的貢獻。其主要項目 TNG908 是一種甲硫腺苷 (MTA) 協同抑制劑，可抑制蛋白質精氨酸甲基轉移酶 5 (PRMT5)，旨在選擇性地作用於甲硫腺苷磷酸化酶 (MTAP) 缺失的癌細胞。其 TNG260 是同類首創的抑制元件 1 沉默轉錄 (CoREST) 的輔抑制劑。該公司的項目還包括 TNG348 和 TNG462。 TNG348 是泛素特異性蛋白酶 (USP1) 的變構抑制劑。

Tango Therapeutics Inc簡介



公司代碼TNGX

公司名稱Tango Therapeutics Inc

上市日期Sep 03, 2020

CEODr. Barbara Weber, M.D.

員工數量155

證券類型Ordinary Share

年結日Sep 03

公司地址201 Brookline Avenue

城市BOSTON

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編02215

電話18573204900

網址https://www.tangotx.com/

公司代碼TNGX

上市日期Sep 03, 2020

CEODr. Barbara Weber, M.D.

Tango Therapeutics Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Ms. Daniella Beckman, CPA

Chief Financial Officer

98.90K

+6.68%

Dr. Adam S. Crystal, M.D., Ph.D.

President - Research and Development

69.70K

+5.90%

Dr. Malte Peters, M.D.

Independent Director

11.25K

+125.00%

Mr. Alexis Borisy

Independent Chairman of the Board

11.25K

+125.00%

Dr. Mace Rothenberg, M.D.

Independent Director

11.25K

+125.00%

Ms. Lesley Ann Calhoun

Independent Director

6.25K

--

Mr. Elizabeth Hickin

Vice President, IR and Corporate Communications

--

Dr. Barbara Weber, M.D.

President, Chief Executive Officer, Director

--

Mr. John Ketchum

Independent Director

--

Mr. Kanishka Pothula

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Ms. Daniella Beckman, CPA

Chief Financial Officer

98.90K

+6.68%

Dr. Adam S. Crystal, M.D., Ph.D.

President - Research and Development

69.70K

+5.90%

Dr. Malte Peters, M.D.

Independent Director

11.25K

+125.00%

Mr. Alexis Borisy

Independent Chairman of the Board

11.25K

+125.00%

Dr. Mace Rothenberg, M.D.

Independent Director

11.25K

+125.00%

Ms. Lesley Ann Calhoun

Independent Director

6.25K

--

收入明細

暫無數據

暫無數據

業務

地區

暫無數據

股東統計

更新時間: 8月16日週六

持股股東

股東類型

持股股東

佔比

Third Rock Ventures, LLC

10.16%

TCG Crossover Management, LLC

8.03%

EcoR1 Capital, LLC

7.96%

Boxer Capital Management, LLC

7.31%

Farallon Capital Management, L.L.C.

6.85%

其他

59.68%

持股股東

佔比

Third Rock Ventures, LLC

10.16%

TCG Crossover Management, LLC

8.03%

EcoR1 Capital, LLC

7.96%

Boxer Capital Management, LLC

7.31%

Farallon Capital Management, L.L.C.

6.85%

其他

59.68%

股東類型

持股股東

佔比

Investment Advisor

32.10%

Hedge Fund

31.25%

Investment Advisor/Hedge Fund

15.46%

Venture Capital

12.31%

Corporation

3.71%

Individual Investor

1.27%

Research Firm

0.61%

Family Office

0.53%

Bank and Trust

0.07%

其他

2.69%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

307

122.99M

94.17%

+2.62M

2025Q2

313

119.32M

107.84%

-16.77M

2025Q1

320

116.84M

107.85%

-22.33M

2024Q4

310

116.06M

107.37%

-22.45M

2024Q3

292

115.54M

108.00%

-9.29M

2024Q2

286

112.62M

105.54%

-13.62M

2024Q1

280

112.63M

105.80%

-9.88M

2023Q4

261

107.66M

105.42%

-11.67M

2023Q3

235

102.78M

102.09%

+4.42M

2023Q2

224

81.67M

92.47%

-10.11M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Third Rock Ventures, LLC

14.06M

12.64%

-1.59M

-10.18%

Sep 25, 2025

TCG Crossover Management, LLC

10.74M

9.65%

--

Jun 30, 2025

EcoR1 Capital, LLC

10.63M

9.55%

--

Jun 30, 2025

Boxer Capital Management, LLC

9.77M

8.78%

-609.51K

-5.87%

Jun 30, 2025

Farallon Capital Management, L.L.C.

9.16M

8.23%

+4.55M

+98.59%

Jun 30, 2025

Woodline Partners LP

6.03M

5.42%

+5.52M

+1091.24%

Jun 30, 2025

Adage Capital Management, L.P.

5.91M

5.31%

+5.91M

--

Jun 30, 2025

Invus Public Equities Advisors, LLC

5.88M

5.29%

+2.52M

+74.84%

Sep 19, 2025

Nextech Invest, Ltd.

5.53M

4.97%

--

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

4.95M

4.44%

+1.21M

+32.30%

Jun 30, 2025

持股ETF



更新時間: 11月2日週日

機構名稱

佔比

Virtus LifeSci Biotech Clinical Trials ETF

1.2%

Invesco Dorsey Wright Healthcare Momentum ETF

1.07%

Invesco Dorsey Wright SmallCap Momentum ETF

0.95%

SPDR S&P Biotech ETF

0.31%

Direxion Daily S&P Biotech Bull 3X Shares

0.18%

iShares Micro-Cap ETF

0.13%

ProShares Ultra Nasdaq Biotechnology

0.1%

Invesco Nasdaq Biotechnology ETF

0.1%

Vanguard US Momentum Factor ETF

0.06%

iShares Biotechnology ETF

0.05%

Virtus LifeSci Biotech Clinical Trials ETF

佔比1.2%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比1.07%

Invesco Dorsey Wright SmallCap Momentum ETF

佔比0.95%

SPDR S&P Biotech ETF

佔比0.31%

Direxion Daily S&P Biotech Bull 3X Shares

佔比0.18%

iShares Micro-Cap ETF

佔比0.13%

ProShares Ultra Nasdaq Biotechnology

佔比0.1%

Invesco Nasdaq Biotechnology ETF

佔比0.1%

Vanguard US Momentum Factor ETF

佔比0.06%

iShares Biotechnology ETF

佔比0.05%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據